Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > Shorts
View:
Post by BioTeck on Feb 22, 2021 11:00am

Shorts

Over 2.8 mil short position added since early Feb. Some news post deal close should send us up quickly especially with the lower volume trading days as of late. I'm surprised we haven't heard the deal being increased by the allowable over allotment amount. It might happen with the deal closing news.
Comment by woundedknee on Feb 22, 2021 2:30pm
Shorts..the scum of the earth. Always, always, said it should be illegal..or maybe just naked shorting illegal and enforced. They say shorts "balance" the market. Bullsh!t, it destroys good business at times and shorters have no conscience.
Comment by Charly50 on Feb 22, 2021 3:32pm
I fully agree. They're goddamn leeches. A very unscrupulous attack is going on. You can't get your throat full ......
Comment by rixpix on Feb 22, 2021 3:40pm
WK,, A few friends of mine have invested in pps in the past. (not here) What they would sometimes do is buy the PP, then short the shares. So let's say they buy a PP @ 1.20 when the shares are trading @ $1.50. They short @1.50, and then close their position with the PP shares when the lockup period expires, leaving them with a net profit and free warrants. This way their initial investment was ...more  
Comment by Rc0gburn on Feb 22, 2021 8:17pm
Rixpix, this short into a PP leaving residual warrants is indeed a common trade. However, one needs to secure a good borrow so you can hold the short AND finance the short over the 4month hold period. Some of the shares have tough borrow and/or super expensive borrow rates - like 50% annualized etc. Its not a free arbitrage.... Yo can also short the shares and trade the ranges  - based on ...more  
Comment by JonEcash on Feb 22, 2021 10:13pm
I don't believe these latest financing units have a hold period. Such a 3-4 month hold is usually explicitly stated in the NR.  Can anyone else confirm? Even if the sp were to drop 20 cents (which I don't think will happen), we would still be trading well above the deal price. Which a very strong sign. Not to mention the volumes are pretty low, meaning there's not much more to ...more  
Comment by woundedknee on Feb 23, 2021 7:25am
rixpix..if shorting was illegal..then they couldn't do that. I have always assumed that if a person or persons partook of a pp at a certain price(which is generally lower than the present market price) then they must have enough info on the company to expect a profit. Remember that in practically all private placements there are additional cheap warrants thrown in with the deal. And then of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities